Thus, these two tumor hybrids together with parental HS578T-Hyg breast cancer cells were chosen to explore the role of ZEB1 and its CRISPR/Cas9 KO in migration, invasion and prospective CSC properties. The gene discussed is ZEB1; the disease is breast carcinoma.